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Review ofAvailable Data on the Growth Rate ofHuman Tumours
THE sparsity of data on the growth rate of human tumours is the result oftwo
principal limitations. Firstly, the number of sites in the body at which more than
one measurement of tumour volume can normally be made is strictly limited to
two classes oftumours, those which occur superficially and are therefore accessible
to direct measurement and those which can be clearly defined on a radiograph.
The second limitation is on the number of cases in which it is justifiable to withold
treatment during the observation period. Mainlyasaresultofthesetwoconstraints
those data which have been reported are subject to a high degree of selection. and
this factor must be borne in mind whenever inferences are made about the general
behaviour of cancer in man. To emphasise this point, the available data will be
classified by tumour site for the purpose of this review. In comparing the work
of different authors the parameter of tumour volume doubling time will be used,
since this has been the custom in most of the published literature. Doubling time
has the advantage over other parameters such as " exponential growth constant "
(Spratt and Spratt, 1964) that it allows one easily to form a mental image of the
rate ofgrowth ofa tumour. Provided that the data allow reliable tumour volumes
to be estimated, this parameter is also preferable to values of rate of growth of
tumour diameter because on tumours ofwidely different sizes it indicates the specific
rate ofexpansion. However, doubling time is a parameter which is only rigorously
applicable to pure exponential curves. Its use in the context of human tumour
growth curves, where the quality ofthe data always leaves some uncertainty about
the precise equation of growth, is on the following definition: the doubling time
of a tumour is the doubling time of the exponential which, on a semilogarithmic
plot, is a tangent to the growth curve at the point of interest.
Comparions between authors involve comparison of distributions of tumour
doubling time in different series of cases. For the purpose ofthis review the limits
ofthe range will be quoted, together with the median doubling time (the inid-point
of a list ranged in order of increasing doubling time).
(i) Tumour metastases observed in the lung
The greatest amount ofpublished data is available for metastatic deposits in the
lung, on account of the ease with which the tumour outline may often be seen
radiographically. Selection exists here also, however, for only in certain regions
of the thorax can a clear shadow be traced. The practicability and tlle sig-
nificance of the measurement of lung metastases was stressed by Collins. Loeffler
and Tivey (1956) in a paper whiclh has had an important effect on the thinking ofGROWTH RATE OF HUMAN TUMOURS
radiologists. The interpretation of their results will be discussed below. Their
growth data are on 24 patients with pulmonary metastases from primaries in
various sites; with one exception, actual growth curves are not given but tumour
doubling times are quoted which range from 11 days to 164 days with a median of
42 davs. Collins et al. divided their data into three equal groups: rapidly-growing
tumours with doubling times below 25 days. slowly-growing tumours with doubling
times in excess of 75 days, and an intermediate group. The data on the one case
for which seven successive measurements of tumour diameter are given shows
astonislhing precision of measurement. A plot of tumour volume against time canl
be fitted by an exponential growth curve from which the experimental points
(leviate on average by only 5 per cent.
In a later paper, Collins (1962) presented the measured doubling times of 25
pulmonary metastases from carcinoma of the colon and rectum. Most of these
were found to fall in the slowly-growing " third " (here on thebasisofmeasurements
oI 180 pulmonary metastases, the rapidly-growing third having doubling times
below 35 days and the boundary of the slowly-growing third still being 75 days).
The metastases from colon and rectum had doubling times ranging from 34 to 210
davs, with a median of 96 days. Similar figures for this type of tumour were
obtained by Welin, Youker and Spratt (1963) on a series of 18 patients.
Schwartz (1961) gives detailed experimental results for 8 patients with pul-
monary metastases. Four ofthese had tumour doubling times below 35 davs, one
fell into Collin's intermediate group whilst another, claimed to be a secondar-
from malignant melanoma, did not change in size over an observation period of
2 .5 moniths. Individual size measurements show understandable scatter, but are
generally consistent with exponential growth not only for the smaller tumours but
also up to a weight of 500 grams. In three patients in whom multiple metastases
were measurable there was good evidence that within ain individual patient metas-
tases have sinlilar growth rates.
Spratt. Ter-Pogossian and Long (1963) examined experimentallv the abilitv
of a group of radiologists to detect metastatic shadows on conventional chest
radiographs. Radiographs were taken in which balls of lucite placed on the
anterior and posterior thorax simulated the presence of intra-thoracic tumours.
It was found that the radiologists could distinguish 10-12 min. diameter balls
regardless of their location. 6 mm. balls could be detected when the shadow was
in a favourable site, and 3 mm. shadows could only be found when the radiologist
was shown precisely where to look. The tests were, however, only concerned with
the detection of lesions; it would have been valuable if the precision of measure-
ment could also have been determined. Schwartz (1961) regarded 1 cm. diameter
as the smallest pulmonary lesion which was radiographically detectable, though his
claim that for lung metastases " 1 mm. reproducibilitv was generally obtainable
presumably applies to ratlher larger shadows.
In a later paper. Spratt and Spratt (1964) presented data on the growth of lung
metastases in 118 patients. on many of whom post mortem examinations had been
performed, and these data constitute a valuable body of information on the
natural history of pulmonary metastases particularly as regards the mean growth
rate of metastases of known histological type. There is much less evidence on the
shape of the growth curves; often the number of experimental points for each
tumour is three or less and occasionally there are sudden changes in growth rate.
However, the size of the tumour at post mortem in general agreed -well with an
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extrapolation of the radiographic observations and the authors are justified in
concluding that the curves are " predominantly linear " on semilogarithmic plots.
Mean doubling times are reported for lung metastases from various primaries.
These ranged from 42 to 109 days with a median of 53 days. There was no sig-
nificant sex difference, but good evidence that in patients under the age of 30 the
mean tumour growth rate was significantly higher. In his paper on the growth of
skeletal sarcomas, Spratt (1965) obtained doubling time measurements on a series
of six pulmonary metastases from bone. These ranged from 19 to 72 days with a
median of 32 days. Half of these tumours therefore fell into Collin's rapidly-
growing group.
At the time of writing, the data of Breur, published in Dutch, has not been
fully translated (Breur, 1965). It is clear, however, that Breur has made an
important contribution to the study ofthe growth ofhuman tumours. His data on
a series of 86 cases with measurable lung metastases from various primaries show a
range of doubling times from 10 days to 745 days, with a median of 42 days.
Breur concluded that in 70 cases on which more than two measurements oftumour
volume were obtained, the data were consistent with exponential growth and that
different pulmonary metastases in the same patient had similar growth rates.
It would seem that there is now a useful body ofinformation on the growth rate
of lung metastases exceeding 1 gram in size. The range of tumour doubling times
found in all these studies is so great that any inter-comparison of the distribution
ofdoubling time would reflect mainly the selection of cases; this would also apply
to any further studies ofthis type. What are therefore now required are attempts
to relate tumour doubling time to some other parameter, either to the clinical
course of the disease or to some aspect of tumour histology.
(ii) Primary lung tumnours
The larger part of the work of Schwartz (1961) was concerned with primary
carcinoma of the lung. The results on 12 patients on whom at least four serial
radiographs were obtained show a range ofdoubling times from 17 to 200 davs, with
a median of 62 days. Schwartz concluded that " spontaneous deviations from an
established growth pattern are rare, even when a tumour has obtained large
proportions"; a careful inspection of his data on primary lung tumours shows,
however, that this should not be taken to imply thattheestablishedgrowthpatterns
were always exponential. In those casesonwhichdatawasavailableapproximately
half the growth curves are slightly but unmistakably convex upwards oni a semi-
logarithmic plot.
Garland, Coulson and Wollin (1963) reportedgrowth data on 41 cases ofprimary
lung tumours. For most ofthese cases only two or three serial measurements were
obtained and the data do not allow any conclusion to be drawn about the shape of
the tumour growth curve. The observed tumour doubling times ranged from 27 to
500 days with a median of 90 days. Classification oftumours by histological type
showed no significant difference in growth rate.
Spratt, Spjut and Roper (1963) also attempted to find statistical differences
between the growth rates of primary lung tumours of various histological types.
In a series of 22 cases they demonstrated significant differences between variances
ofthe growth rates ofadenocarcinoma, epidermoid carcinoma and undifferentiated
carcinoma, but could not conclude anything about the differences in the mean rates
ofgrowth. Despite the fact that these authors were not on the basis oftheir data
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able to distinguish between exponential and " cube root " growth curves, they
nevertheless computed estimated durations for exponential growth from the size
of a single cell.
(iii) Tumours in other sites
Bone tumours form another class of neoplasm in which the primary growth is
amenable to accurate localisation on a radiograph. Spratt (1965) examined a
series of 8 primary osteogenic tumours. These were reported to have doubling
times which fell into two groups, one around 25 days, the other in excess of 128
days, these groups cutting across the histological classification. With such an
unusual distribution of doubling times, any measure of central tendency is of
doubtful value; Spratt quotes a geometric mean of 36 days. Growth curves are
given, but the portions of these which refer to untreated tumours are so small that
no conclusions can be drawn about the shape of the tumour growth curves; for
the samereasonthe precision ofthe doubling time measurements is difficult to judge.
The work of Welin, Youker and Spratt (1963) has provided valuable data on
the growth rate of primary tumours of the colon and rectum. Using a carefully
designed (" double contrast enema ") technique they claimed to be able to detect
lesions as small as 3 mm. in diameter and that their total margin of errorwas only
± 2 mm. on the measurement of a diameter. Their justification for this claim is,
however, not clear. Tumours in this anatomical site commonlv occur as circum-
ferentially spreading plaques and the tumour volume was therefore calculated by
assuming the tumour to be cylindrical in shape. Even allowing for the uncertainty
in volume which clearly exists here, there is no doubt that the rate of growtlh of
tumours in this series (375 tumours in all) is considerably slower than for other
tumours on which growth measurements have been made. The authors conclude
that most malignant tumours in this site had doubling times in the range 138 to
1155 days although in some cases no growth was detected. They also concluded,
despite the precision which they claim for their measurement of tumour diameter,
that it was impossible to distinguish between linear and exponential growth curves.
There seems to be no doubt that for tumours of the colon and rectum the primary
growth has on the average a distinctly slower rate of growth than its pulmonary
metastases: Spratt (1965) may have touched on an important point in implicating
the loss of cells by surface desquamation as the cause of this difference.
Ingleby, Moore and Gershon-Cohen (1960) have shown that when circumstances
permit more than one radiographic examination of untreated tumours of the
breast, useful growth data may be obtained. They present a series of 16 cases in
which growth measurements were possible, and when their data are recalculated in
terms of volume doubling time the range is 81 to 900 days (median 285 days).
Ingleby et al. suggest that whilst they might expect exponential growth in lung
tissue, they could not postulate this for tumours of the breast on account of its
relative inhomogeneity. The relatively low precision of measurements on breast
tumours and the small range of tumour volumes over which they can usuallv be
made have so far combined to prevent experimental confirmation of this view.
The Growth Curves of Human Tumours
One can conclude from a review of the literature that whilst there is now a
considerable body of evidence on the range of volume doubling times of a selection
of human tumours, the evidence on the rate of change of doubling time is still quite
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sparse. Growth rate data are now available (see previous section) on tumours of
four primarv sites and on pulmonary metastases, but only in the case oftumours of
the lung have meaningful growth curves been obtained. One must be conscious of
this in attempting to extend any theoretical deductions to tumours of otlher sites.
OIn account ofthe inadequacy of our information in this respect one is forced to
make use of the circumstantial evidence provided by studies of tumour growth in
experimental animals. Such evidence must be treated with caution, particularly
since there is no doubt that the rate of growth of human tumours is much lower
than that of most experimental tumours in small ailimals, whether transplainted,
induced or spontaneous. But one general observation from small animal work is
that tumour growth curves when plotted on semilogarithmetic co-ordinates are
invariably convex upwards, at least when the data are averaged to eliminate the
peculiarities of individual curves. The reviews of Mendelsohn (1963) and Laird
(1964) make this clear. Mendelsohn suggested that the deviation from exponential
ofany portion ofa tumourgrowth curve could usefully be specified by the exponient
b in the appropriate solution of the differential equation
dM kMb . . (i)
dt
wlhere 11 is the observed tumour mass and k is an arbitrary constant. Laird
founid that a wide variety ofexperimental tumour growth curves can be fitted by a
Gompertz equatioin, which has the characteristic of a doubling time which increases
with an exponential function of time. The exponential growth curve is the
limiting case of both these treatments, and it is usually best approximated by
tumours in the earlier part of their observed growth period.
With this background, it is difficult to expect any different situation in humain
tumour growth, the more so because the tumours measured in radiographic
survevs have been relatively large, often in the range 1 to 100 grams in weight.
Spratt (1965) argues that we do not know at what size human tumours might be
expected to depart from exponential growth. It could be that the departures
found in the experimental animal tumours to some extent occur because the
tumours reach a significant proportion of the host body weight. If this were an
important factor, then one might expect tumours in man to grow exponentially to
a muclh larger absolute size. However, whilst one would expect a deviation from
exponential when the tumour begins to become a major drain on the metabolic
resources of the host, one would also expect a deviation at a point which is depen-
dent on absolute tumour size. Thegrowth rate ofa tumour depends on the inherent
proliferative capacity ofwell-vascularised tumour tissue but also on the proportion
of the tumour which is well-vascularised. The work of Thomlinson and Gray
(1955) emphasised the importance ofthe capillary system in the growth oftumours
and showed that cell proliferation would not be expected beyond about 150
micronis from a capillary. When an exponentially-growing tumour is small the
conditioni ofsatisfactory vascularisation may be attained but, as it grows, vascular
accidents may lead to central necrosis and furthermore, since the perimeter of the
tumour is also growing exponentially, it may become increasingly difficult for the
proliferation ofcapillaries nearthe surface ofthe tumour tokeep up withthe volume
inerease. From both of these points of view an upper limit on the size which a
tumour can reaclh by exponential growth is to be expected. This upper limit will
depend on tumour growth rate but in any partially-necrotic tumour it could be
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assumed that the limit has been passed and that the tumour has already begun to
grow more slowly.
In view of these considerations, little support can be given to the suggestion
sometimes made that the point of departure from assumed exponential growth
might be proportional to the body weight ofthe host and that iftumours in the rat
generally deviate from exponential growth at about 1 gram in size (Fig. 1), then
tumours in man might be expected to keep a constant doubling time up to a weight
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FIG. 1. Growth curve for a transplanted rat tumour. Originally a mammary tumour, it has
now gone through over 400 subcutaneous transplants in the August female rat. Volume
doubling time at 0-1 g. is 26 hours. Vertical bars give the range of measurements on nine
tumours.
of 100 grams or more. There remains, however, the fact that in studies of the
growth curves of human lung tumours there is a preponderance of those which
approximate to exponential. Such tumours are commonly 10 to 100 grams in
size; Schwartz (1961) found one primary lung tumour where growth was consistent
with an exponential curve from 5 to 2000 grams. There are two possible explana-
tions for these apparent exceptions to the general observation that as tumours
become larger their doubling time increases:
(i) It may be that some controlling factor operates, for instance on the cell cycle
time or growth fraction of the tumour, to produce an inherent verv slow growth
rate even of well-vascularised tumour. In such a situation difficulties of necrosis
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miglht not arise, aind in the absence of progression an exponential growth curve
might be followed up to large tumour volumes. Cell proliferation studies on well-
vaseularised tumour tissue are needed to confirm or reject this possibility.
(ii) It is not inconceivable that a large and heterogeneous mass consisting of a
relatively small amount of well-vascularised tissue proliferating at a fairly high
rate. together with a larger amount of poorly vascularised tissue having severe
vascular difficulties, might as a statistical result of its overall heterogeneity,
achieve a slow exponential growth rate. This would be a difficult hypothesis to
conifirmil, but ifwell-vascularised tissue in such a tumour were found to have a high
proliferation rate, this would be supportive evidence. Exponential growth does
not require that all cells should be proliferative, merely that on average froin every
division a constant proportion of the daughter cells continue to proliferate at the
same rate as the original cell.
The above hypotheses (i) an (ii) might be called respectively " Inherent Slow
Growth " and " Restricted Slow Growth ". Which ofthe two is nearest the truth
is important from various points ofview. Extrapolation back in order to estimate
the time of induction assumes Inherent Slow Growth, for Restricted Slow Growth
implies that when the tumour was smaller it could grow more rapidly. Also, cell
cycle time in tumours is one ofthe factors to be taken into account in the choice of
dose fractionationi techniques in radiotherapy and the hypothesis of Inherent Slow
Growth may imply that cell cycle times are almost as long as the tumour doubling
times. To decide which of these two hypotheses is the more valid is a major
objective of studies of cell population kinetics in tumours.
T'he Feasibility of Predicting Times of Induction from the Growth Curves of Human
Tumnour8
In the literature on humain tumour growth it has been a widespread practice,
on finding a growth curve which approximates to an exponential, to extrapolate
this back to the initial size of a small clone of cells in the hope that the time inter-
cept may indicate the time at which tumour induction was completed. Since a
detectable humain tumour contains in the region of 109-1010 cells, the extrapolation
must be over about nine orders of mangitude of tumour size and it is immediately
clear that this must involve considerable uncertainty.
In the paper ofCollins et al. (1956) the authors clearly emphasised the fact that
if exponential growth over the whole life of a tumour can be assumed, then the
preclinical period must greatly exceed the period from first symptoms to death of
the host. They also stressed the facts that the apparently sudden appearance ofa
rapidly-growing lump may not be inconsistent with regular exponential growth,
and that the absence of detectable lung metastases should not be taken to mean
that microscopic growths may not be present. The procedure of exponential
extrapolation can also be applied to predict possible times ofrecurrence, and Collins
and his co-workers were able to show that for a series of 206 children with Wilms'
tumour theriskofrecurrence agreedwellwiththeoretical predictionbythemethodof
Boag (1949) and also were consistent with predictions on the basis of exponential
growth.
Subsequent authors (see Schwartz, 1961) have reiterated the theory of ex-
ponential growth without adding greatly to it; others have merely used the theory
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to predict the total " duration " of tumours. It has usually been assumed that the
precision of such estimates is sufficiently good to be worthwhile and it is therefore
necessary to discuss the uncertainties which are involved.
The totalportion of agrowth curve which cannormally be obtained for a human
tumour (at best a 20-fold or 100-fold variation in tumour volume)is insufficient for
more than the first differential (slope) and the second differential (curvature) to be
established in a semi-logarithmic plot. If the second differential is not zero, then
a wide variety ofalgebraic functions could be found to fit the data. This fact by
itself is an indication of uncertainty. Now if a slight curvature exists, or if the
data is insufficiently precise to rule out a slight curvature, what effect could this
have on the estimate of the " silent interval "? (Schwartz's term for the period of
undetected growth). The differential growth equation (equation (i) above) put
forward by Mendelsohn (1963) provides one possible approach. Values of the
exponent b correspond to solutions ranging from linear growth (b - 0) to exponen-
tial growth (b 1) with a whole series of power-law solutions in between (for
b= 2j3 we get "cube-root " growth). The exponent b is thus a measure of how
far a fitting solution deviates from exponential growth. We may now ask, if a
particular set ofgrowth data does not exclude a value of b as low as sav 0 9. what
is the possible error in the prediction of the silent interval? For example. we may
take the situation in which a tumour has a weight of 1 gram when first seen. and in
whiclh at that time the growtli rate (dt corresponds to a doubling time of 30
days. Possible growth curves for different values of b are shown in Fig. 2. Bear-
ing in mind the limited precision of measurements on human tumours and the
relatively small range of tumour size on which they are usually made, one can
judge from Fig. 2 the degree of certainty with which one could establish the
equation of growth in a particular case. One might expect to be easily able to
distinguish linear growth from exponential growth (though this has been doubted
by Welin et al. (1963) for their work on primary tumours of the colon) but it is
clear that an uncertainty of 10% or even 30% in b would not be surprising. The
backward extrapolation of these curves is shown in Fig. 3. For small values of b
the curves approach asymptotically a time intercept which is shorter than the
silent interval obtained by exponential extrapolation. Fig. 4 shows the time
within which the curves rise from 10-9gram to the point of initial detection. For
most values of b the extrapolated curves come down so steeply that at some point
the volumedoubling time falls below a value of 10 hours. Since this approximates
to the shortest cell cycle time found in mammalian systems any shorter doubling
time must be regarded as being unbiological. This is indicated in Fig. 4 but it
remains that for values of b close to unity, the predictions are reasonable, and it
can be seen that in this region the extrapolated silent interval is changing very
rapidly with b-value. An uncertainty of 10% in b may thus affect the silent
interval by a factor of two. It is not claimed that tumours do follow solutions to
the Mendelsohn equation, only that on the basis ofthe present data one cannot say
that they do not. The limit oferror could in fact be greater than that predicted on
this basis.
It is clear therefore that any slight deviations from exponential in tumour
growth curves can give rise to large errors in estimates of silent interval.
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This discussion has, however, been concerned purely with the mathematical
aspects of possible error. Very relevant also to the validity of exponential
extrapolation are the concepts of tumour progression and the choice between the
hypotheses of Inherent Slow Growth and Restricted Slow Growth outlined above.
Tumour progression (Foulds, 1956) is now a widely accepted concept and it would
lead one to expect a decreasing volume doubling time as those cells or cell lines
which have the shortest cell cycle time and the greatest resistance to host defences
gradually outgrow the rest of the tumour cell population. Restriction of growth
implies an increasing volume doubling time, and therefore from a purely biological
point of view one might expect the full growth curve for a tumour to be sigmoid in
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FIG. 2.-Theoretical growth curves for a tumour which at time zero has a weight of 1.0 g. and a
growth rate which by exponential growth would give a volume doubling time of 30 days.
Curves are plotted for various values of the exponent b of equation (i).
shape when plotted seinilogarithmically. It is conceivable that in some particular-
case extrapolation back of the terminal portion of a growth curve could in fact
indicate the true time of induction, purely by a coincidental combination of early
progression and late restriction.
Whilst in the published literature on the growth of human tumours extrapola-
tion has always been by an assumed exponential curve, the availability of more
complete data on experimental tumours enables one in principle to make a more
sophisticated extrapolation. This has been done by Laird (1964, 1965) using the
Gompertz equation. This equation has three arbitrary constants and by suitable
choice of these a wide variety of tumour growth curves can be simulated and thus
extrapolated. This approach is clearly preferable when the quality of the data
justifies it but it is not immune to the criticism that it ignores tumour progression.
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The Gompertz equation in fact approximates closely to an exponential when the
tumour is relatively small. Furthermore, Laird's work has shown that in some
cases the predicted doubling times of small tumours are considerably less than 10
hours which quite invalidates the extrapolations in these cases. It would seem
therefore that even when the experimental data are relatively complete and extra-
polation is on the basis of a well-fitting curve, one still cannot have confidence in
predictions of silent interval. Only actual experimental evidence on the growth
rate of microscopic tumours can resolve the situation.
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Fie.. 3.-Extrapolation of the growth curves ofFig. 2. The -exponential reaches a tumour size of one
cell (10-'1 g.) at - 900 days.
The Contributionfrom Studie8 of Cell Proliferation in Tumours
Many of the problems in our understanding of the overall growth of tumours
arise out ofignorance ofthe basic characteristics oftheproliferating cellpopulation,
despite the fact that techniques of investigation of cell population kinetics have
been developing rapidly over the past ten years (Wimber, 1963). The application
ofthese techniques to experimental tumours has been shown to befeasible and data
are now available on a variety of tumour types (Mendelsohn, Dohan and Moore,
1960; Mendelsohn, 1960, 1962; Bertalanffy and Lau, 1962; Bertalanffy, 1963;
Edwards et al., 1960).
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The problem of measuring cell production rate in a tumour is essentially the
same as in normnal tissues. The basic concept is that of the distribution of cell
cycle time : individual cells will have cell cycle (intermitotic) times varying from a
minimum value of perhaps 10 hours up to indefinitely long values in the case of
cells which for some reason cease to divide. In rapidly-proliferating normal
tissues such as intestinal epithelium (Cairnie, Lamerton and Steel, 1965) the distri-
bution ofcell cycle times may be quite narrow but in any tumour in which there is a
vascular limitation on the size ofthe proliferating cell population one might expect
a rather broad distribution, with many cells not dividing at all. It was on this
basis that Mendelsohn (1962) introduced the concept of " growth fraction ", the
fraction of cells which are proliferating. Clearly, the use of this term involves a
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Fic.. 4. Duration of the " silent interval " for growth from 10-9 g. to 1-0 g. for various values of
the exponent b. Values less than about 0-8 involve tumour doubling times which are initially
less than 10 hours, and therefore regarded as being unbiological.
definition of the boundary between proliferation and non-proliferation but when
this can be decided the experimentally difficult problem of determining the distri-
bution of cell cycle times and hence the cell production rate can be reduced to the
measurement of two parameters:
(i) the growth fraction
(ii) the mean cycle time of proliferating cells.
'I'hus slow tumour growth could be the result of a long cell cycle time with a large
growth fraction, or a short cell cycle time coupled with a small growth fraction.
The first problem in the study ofcell proliferation in tumours is to be able to decide
between these two alternatives.
As regards cell proliferation in human tumours, the experimental difficulties are
very great. However, in the light of a detailed knowledge of the situation in
experimental tumours it may be possible to plan simple investigations yielding the
maximum amount ofinformation. Apart from mitotic index, the only parameter
of cell proliferation which has so far been determined in human material is a
thymidine labelling index. Occasionally this has been obtained by in vivo
labelling (Johnson, Rubini, Cronkite andBond, 1960; Clarkson, Ota and Karnofsky,GROWTII RATE OF HUMAN TUMOURS
1962) but nmore commonly in vitro labelling techniques have been used (Johnson
and Bond, 1961; WAolberg and Brown, 1962 ; Oehlert, D6rmer and Lesch, 1963;
Reid, 1964; Titus and Shorter, 1965; Steel and Bensted, 1965). Despite the
considerable amount of work which has been done in this direction, little attempt
has been made quantitatively to interpret thymidine 1abelling index. There are
difficulties in this, but a possible approach has been suggested by Steel and Bensted
(1965) who examined the relationship between labelling index and tumour doubling
time. A relationship can be demonstrated theoretically for certain model cell
populations and if a sufficient variety of tumours can be found in which both
doubling time and labelling index are measurable then experimental confirmation
should be possible. The value of such a relationship, ifit exists, is that in the case
of human tumours, measurements oftumour doubling time can be made on a wide
variety ofinaccessible tumours and in the case ofexperimental tumours it becomes
possible to examine the growth rate of microcarcinomas.
CONCLUSIONS
It isdifficult to avoidthe conclusionthatmuchofthediscussion intheliteratureof
the exponential growth ofhuman tumours and the durationofthe " silent interval "
has been based on insufficient evidence. It may well be that under certain cir-
cumstances the exponential extrapolation of a growth curve does yield valid
results. However, the present examination of the literature has indicated that
this need not be the case, but that errors of a factor oftwo or more in the estimate
of silent interval may be expected.
Other aspects ofthe growth ofhuman tumours are more deserving ofthe atten-
tioII ofinvestigators. The remarkably slow growth ofmany neoplasms is yet to be
explained. Is this inherent in the cell proliferation ofwell-nourished tumour tissue
or is it the result ofrestrictions imposed by the vascular system ofthe tumour? It
would be well if the emphasis on the silent interval should lead to detailed experi-
mental studies of the growth of microscopic tumours and a fuller understanding of
the factors which determine the time between induction and the onset ofsymptoms.
It is through an attack on such problems as these that we may hope to gain some
control over the growth rate of human tumours, perhaps even to persuade some of
them to grow more slowly and hence to make them less unpleasant to live with.
SUMMARY
Published literature on the growth rate of tumours in man is reviewed with
particular reference to work which gives significant information on the form of
human tumour growth curves. Only in tumours ofthe lung is the data sufficiently
good to make any deductions about the equation of growth; in this situation the
growth curves seem to be predominantly exponential.
The widespread practice of extrapolating assumed growth curves back to
deduce the time ofinduction is examined. It is shown that slight deviations from
exponential might produce errors ofa factor oftwo or more in the predicted length
of the preclinical period. In addition the unpredictable effect of tumour progres-
sion complicates the situation still further. The need is for experimental evidence
on the growth rate of microscopic tumours.
The occurrence ofslow exponential growth in large lung metastases could either
be the result of an inherent propertv of well-vascularised tumour tissue or the
8586 G. G. STEEL AND L. F. LAMERTON
statistical result of tumour growth being restricted, probably under vascular
limitations. The importance of studies of cell proliferation in deciding between
these two hypotheses is stressed.
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